Institutional investors purchased a net $19.4 million shares of TXMD during the quarter ended March 2014. This may signal that the smart money is gaining interest in this company as the 65.34% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Generic industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.9 Million shares of TherapeuticsMD Inc